Stockscreener 앱 받기
13.42
2.04%
-0.33
전일 마감가:
$13.75
열려 있는:
$13.73
하루 거래량:
335.79K
Relative Volume:
0.38
시가총액:
$594.93M
수익:
$128.29M
순이익/손실:
$-30.69M
주가수익비율:
-16.37
EPS:
-0.82
순현금흐름:
$-27.17M
1주 성능:
-3.44%
1개월 성능:
-4.33%
6개월 성능:
-69.83%
1년 성능:
-77.09%
1일 변동 폭
$13.15
$13.85
1주일 범위
$13.03
$15.41
52주 변동 폭
$13.03
$64.50
Rxsight Inc Stock (RXST) Company Profile
명칭
Rxsight Inc
전화
949-521-7822
주소
100 COLUMBIA STREET, ALISO VIEJO
RXST을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
13.39 | 594.93M | 128.29M | -30.69M | -27.17M | -0.82 |
|
ABT
Abbott Laboratories
|
129.50 | 230.70B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.80 | 154.22B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
388.52 | 145.74B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
85.20 | 107.03B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
74.90 | 44.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-15 | 개시 | Piper Sandler | Neutral |
| 2025-04-09 | 다운그레이드 | UBS | Buy → Neutral |
| 2025-04-04 | 다운그레이드 | JP Morgan | Overweight → Underweight |
| 2025-04-03 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2024-12-20 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-12-11 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | 개시 | UBS | Buy |
| 2024-10-29 | 개시 | Jefferies | Buy |
| 2024-08-20 | 재확인 | Needham | Buy |
| 2024-08-06 | 재확인 | Needham | Buy |
| 2024-05-07 | 재확인 | BTIG Research | Buy |
| 2023-12-13 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-12-12 | 개시 | Stifel | Buy |
| 2023-12-04 | 개시 | Morgan Stanley | Overweight |
| 2023-04-13 | 개시 | Oppenheimer | Outperform |
| 2022-12-12 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-04-08 | 개시 | Needham | Buy |
모두보기
Rxsight Inc 주식(RXST)의 최신 뉴스
Morgan Stanley Adjusts Price Target on RxSight to $20 From $42, Maintains Overweight Rating - marketscreener.com
RxSight, Inc. (NASDAQ:RXST) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Finance
Dimensional Fund Advisors LP Acquires 237,877 Shares of RxSight, Inc. (NASDAQ:RXST) - Defense World
Midday Stock Roundup: Clean Energy Leaps 22% - Orange County Business Journal
Insiders Who Purchased US$1.42m Of RxSight Stock May Not Have Expected 12% Tumble - simplywall.st
Top 3 Health Care Stocks That Are Preparing To Pump This Quarter - Benzinga
RxSight: Favorable Risk/Reward Scenario with Strong Growth Prospects and Attractive Valuation - TipRanks
RxSight (NASDAQ:RXST) Sets New 12-Month Low After Earnings Miss - Defense World
Envestnet Asset Management Inc. Has $210,000 Position in RxSight, Inc. (NASDAQ:RXST) - Defense World
RxSight, Inc. Reports Strong Q1 2025 Revenue Growth - TipRanks
RxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Rxsight Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Earnings call transcript: RxSight reports Q1 2025 earnings beat, stock rises 6.67% - Investing.com Nigeria
RxSight, Inc. (RXST) Tops Q1 EPS by 17c - StreetInsider
RxSight, Inc. Reports First Quarter 2025 Financial Results - GlobeNewswire
In the Green: RxSight Inc (RXST) Closes at 13.95, Up/Down -4.71 from Previous Day - DWinneX
RxSight, Inc. (NASDAQ:RXST) Shares Sold by First Trust Advisors LP - Defense World
RxSight’s Earnings Call: Growth Amid Challenges - TipRanks
RxSight (RXST) Expected to Announce Earnings on Wednesday - Defense World
How to Take Advantage of moves in (RXST) - news.stocktradersdaily.com
Prepare Yourself for Liftoff: RxSight Inc (RXST) - Sete News
RxSight Inc (RXST)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - DWinneX
RxSight Inc (RXST) is a good investment, but the stock may be undervalued - uspostnews.com
RxSight, Inc. to Present at the Bank of America Healthcare Conference - The Manila Times
RxSight, Inc. to Present at Bank of America Healthcare Conference on May 14, 2025 - Nasdaq
RxSight Brings Latest Cataract Surgery Innovation Updates to Major Healthcare Conference - Stock Titan
RxSight, Inc. (RXST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance
Piper Sandler gives a Neutral recommendation for RxSight Inc (RXST) - knoxdaily.com
Russell Investments Group Ltd. Sells 94,412 Shares of RxSight, Inc. (NASDAQ:RXST) - Defense World
JPMorgan Chase & Co. Reduces Stake in RxSight, Inc. (NASDAQ:RXST) - Defense World
RxSight, Inc. (NASDAQ:RXST) Given Average Recommendation of “Hold” by Brokerages - Defense World
RxSight Inc [RXST] Records 50-Day SMA of $23.43 - knoxdaily.com
What Does RxSight, Inc.'s (NASDAQ:RXST) Share Price Indicate? - Yahoo
RxSight, Inc. to Report First Quarter 2025 Financial Results on May 7, 2025 - The Manila Times
RxSight, Leading Eye Surgery Tech Company, Sets Q1 2025 Earnings Release Date - Stock Titan
LPL Financial LLC Boosts Holdings in RxSight, Inc. (NASDAQ:RXST) - Defense World
Geode Capital Management LLC Has $28.57 Million Stock Position in RxSight, Inc. (NASDAQ:RXST) - Defense World
Piper Sandler Initiates Coverage of RxSight (RXST) with Neutral Recommendation - Nasdaq
This Aurora Innovation Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday - Benzinga
Piper Sandler Initiates RxSight at Neutral With $18 Price Target - marketscreener.com
Piper Sandler Begins Coverage of RxSight (RXST) with Neutral Rat - GuruFocus
Piper Sandler sets RxSight stock target at $18, stays neutral By Investing.com - Investing.com South Africa
Piper Sandler sets RxSight stock target at $18, stays neutral - Investing.com
Piper Sandler Starts RxSight Inc. (RXST) at Neutral - StreetInsider
RxSight price target lowered to $17 from $22 at Wells Fargo - MSN
RxSight plunges after guidance cut; BofA downgrades - MSN
RxSight stock plunges to 52-week low at $14.24 amid market challenges By Investing.com - Investing.com South Africa
RxSight stock plunges to 52-week low at $14.24 amid market challenges - Investing.com
UBS cuts RxSight stock rating to neutral, slashes price target to $16 By Investing.com - Investing.com South Africa
RxSight downgraded at UBS after Q1 miss and guidance cut - MSN
RxSight stock downgraded at UBS on guidance cut (RXST:NASDAQ) - Seeking Alpha
Rxsight Inc (RXST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Rxsight Inc 주식 (RXST) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Fountain Tamara | Director |
Mar 12 '25 |
Sale |
25.71 |
7,000 |
180,002 |
24,793 |
0.27%
0.39%
자본화:
|
볼륨(24시간):